INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 214 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,631 | -76.8% | 94,204 | -73.3% | 0.00% | – |
| Q2 2023 | $157,817 | -5.5% | 352,174 | +72.2% | 0.00% | – |
| Q1 2023 | $167,054 | -33.4% | 204,503 | +27.1% | 0.00% | -100.0% |
| Q4 2022 | $251,000 | -14.6% | 160,869 | -5.9% | 0.00% | 0.0% |
| Q3 2022 | $294,000 | -5.5% | 170,875 | -4.8% | 0.00% | 0.0% |
| Q2 2022 | $311,000 | -50.4% | 179,478 | +14.1% | 0.00% | 0.0% |
| Q1 2022 | $627,000 | -6.1% | 157,239 | +17.9% | 0.00% | 0.0% |
| Q4 2021 | $668,000 | -52.3% | 133,376 | -32.0% | 0.00% | -66.7% |
| Q3 2021 | $1,401,000 | -2.6% | 196,018 | +26.4% | 0.00% | 0.0% |
| Q2 2021 | $1,439,000 | +8.4% | 155,076 | +8.5% | 0.00% | 0.0% |
| Q1 2021 | $1,327,000 | +2.3% | 142,904 | -2.4% | 0.00% | 0.0% |
| Q4 2020 | $1,297,000 | -49.9% | 146,460 | -32.5% | 0.00% | -62.5% |
| Q3 2020 | $2,589,000 | -28.8% | 217,003 | +60.9% | 0.01% | -33.3% |
| Q2 2020 | $3,637,000 | +768.0% | 134,878 | +142.6% | 0.01% | +500.0% |
| Q1 2020 | $419,000 | – | 55,603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |